WWMSC
DNA icon

Wagner Wealth Management (South Carolina)’s Ginkgo Bioworks DNA Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-164
Closed -$20K – 359
2022
Q3 		$20K Buy
+164
New +$19.5K 0.01% 312

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s DNA Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Ginkgo Bioworks (DNA) in Q4 2022, closing a stake of 164 shares — an estimated $20K sold.

Wagner Wealth Management (South Carolina) first reported a position in DNA in Q3 2022 and held it in 1 quarter. The position peaked at $20K in Q3 2022. 320 funds tracked by Wall St. Rank hold DNA as of Q4 2022.

  • Wagner Wealth Management (South Carolina) reported no remaining Ginkgo Bioworks position as of Q4 2022 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 164 Ginkgo Bioworks shares in Q4 2022, an estimated $20K.
  • Wagner Wealth Management (South Carolina) first reported a position in Ginkgo Bioworks in Q3 2022 and held it in 1 quarter.
  • Wagner Wealth Management (South Carolina)'s Ginkgo Bioworks position peaked at $20K in Q3 2022.
  • 320 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.